The success of Viagra initially fueled a surge for pharma, but recent developments present a complicated picture for investors. Lower-cost alternatives are reducing profits, and continued patent challenges add https://umairfepz807324.total-blog.com/the-blue-pill-and-big-pharma-a-volatile-play-66696184